ABUS Arbutus Biopharma Corporation

Note: We have detected that our data provider shows 0 for short interest. Please manually confirm and if different, disregard the short data and short pain data below.

$4.365 -0.57%

214,127 Shares Traded
216,090 Average Volume (last 30 days)

as of December 14, 2018 EST IEX Real-Time Price

Click Here to Short Float History Versus Price & Peer Short Floats

Free Newsletter Sign Up


Arbutus Biopharma Corp's (ABUS) CEO Mark Murray on Q3 2018 Results - Earnings Call Transcript (SeekingAlpha)

Short Pain Metrics

Approximate Amount of Money Shorts Have Lost on the Day: $0
If Intiated on the First, Shorts Have Realized a Year to Date Return of:19.45%
If Intiated One Month Ago, Shorts Have Realized a Return of:0.9%
If Initiated Five Days ago, Shorts Have Realized a Return of:0.23%
Peer Rising Stocks Near Real Time Screener
*Please note the actual returns of shorts could be different as they started from different points.

Daily Indicators

Daily Short Pain Indicator [i] - Always Use Fundamentals on EverythingNeutral
200 Day Moving Average Indicator Bearish
50 Day Moving Average Indicator Bearish
52 Week High/Low Indicator Neutral

Short Stats

Short Percent to Float 0%
Short Interest0
Float50.97 million
Short Ratio0
Market Cap$243.55 million
Market Maker ActivityDaily Short Volume

Smart Money Sentiment

Institutional Ownership (Top 15 Funds) 52.9%
Insider Percent8.2%

Earnings Stats

PE Ratio -2.19
Dividend Yield 0%

Earnings History For ABUS

Earnings DateQuarterConsensus EPSActual EPSEPS Surprise
2018-11-07 AMCQ3 2018-0.39 (3 Estimates) -0.30.09
2018-08-02 AMCQ2 2018-0.35 (3 Estimates) -0.44-0.09
2018-05-03 Q1 2018-0.38 (3 Estimates) -0.360.02
2018-03-14 Q4 2017-0.39 (2 Estimates) -0.9-0.51


200 Day Moving Average $6.91
50 Day Moving Average $5.04
52 Week High $12.6
52 Week Low $4.01

Back to the Top

Data provided for free by IEX. Questions? Read the FAQ